{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-071485","form_type":"8-K","ticker":"MREO","cik":"0001719714","company_name":"Mereo BioPharma Group plc","filed_at":"2025-05-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.461612+00:00","generated_at":"2026-05-21T09:06:22.861638+00:00","sec_items":["5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Mereo BioPharma 2025 AGM: all resolutions pass; board elects annual say-on-pay","bullets":["Resolutions 1-5 and 7-9 passed with over 85% of votes cast.","Resolution 6 (advisory vote on frequency of exec comp) received 48% for 1-year, 46% for 3-year; board chooses annual frequency until 2031.","Re-elected directors Deepika Pakianathan, Pierre Jacquet, Michael Wyzga each won >85% support.","PricewaterhouseCoopers re-appointed as auditor with 99.58% of votes cast.","Total 624,188,662 ordinary shares represented at the meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-071485","json":"https://secwatch.observer/filing/0000950170-25-071485.json","markdown":"https://secwatch.observer/filing/0000950170-25-071485.md","text":"https://secwatch.observer/filing/0000950170-25-071485.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1719714/000095017025071485/0000950170-25-071485-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1719714/000095017025071485/mreo-20250513.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T09:06:22.861638+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}